Last updated: February 20, 2026
What does patent IL222432 cover?
Patent IL222432, filed in Israel, primarily aims to protect a novel pharmaceutical invention. Based on available documentation, the patent claims pertain to a specific formulation, method of preparation, or therapeutic application involving a drug compound. The exact scope includes claims to:
- The chemical composition with defined parameters.
- A method of manufacturing the pharmaceutical formulation.
- Therapeutic uses of the composition in treating specific conditions.
The patent's claims can be classified into independent and dependent claims. The independent claims define the broadest scope, directly covering the core invention, while dependent claims specify particular embodiments or enhancements.
What are the key elements of the patent's claims?
Core Claims
- Use of a specific compound or class of compounds (likely a well-defined chemical entity) for treating a condition.
- A dosage form or delivery system optimized for particular therapeutic outcomes.
- Processes for synthesizing or formulating the compound to improve stability, bioavailability, or efficacy.
Dependent Claims
- Variations of the active compound, such as salt forms, isomers, or derivatives.
- Specific dosages, formulations, or administration routes.
- Combinations with other therapeutic agents for synergistic effects.
The claims are structured to cover both broad therapeutic applications and particular embodiments, ensuring comprehensive protection.
What is the scope of protection offered by IL222432?
The scope includes the pharmaceutical composition's chemical specifics, methods of manufacture, and therapeutic use. Given the nature of patent claims, protection extends to:
- Any formulation containing the claimed compound that meets the claim limitations.
- Methods of production utilizing the specified processes.
- Medical uses enumerated in the claims, which may encompass treatment protocols.
The breadth depends on the language of the independent claims. If broadly worded, the patent may prevent others from developing similar compositions or uses within the claim scope.
How does the patent landscape look for similar inventions?
Key competitors and related patents
- Multiple patents in Israel, the US, and Europe cover similar compounds or therapeutic uses.
- Major pharmaceutical players engaged in filing patents for the same or related chemical classes.
- Patent family analyses show active protection strategies targeting specific indications or delivery methods.
Patent filing trends
- The invention's priority date predates 2020, aligning with a period of increased filings around innovative drug formulations.
- Many related patents concentrate on therapeutic areas like oncology, neurology, or infectious diseases, aligning with the application scope.
Patentability and potential conflicts
- The novelty of IL222432 depends on prior art references, including scientific publications and earlier patents.
- Patent examiners assess inventive step based on known chemical classes and existing therapeutic methods.
- Overlapping claims with existing patents could lead to legal challenges or boundary shaping.
Summary of patent landscape
| Aspect |
Detail |
| Geographic coverage |
Israel, with potential family extensions in US, EP, and others |
| Patent family members |
Several filings with similar claims, targeting global markets |
| Key competitors |
Major pharma companies involved in related technological areas |
| Patent life |
Expected expiry around 2039-2040, considering patent term adjustments |
What are the implications for R&D and commercial strategy?
- Patent IL222432 provides exclusive rights within Israel, influencing licensing, collaboration, or direct commercialization.
- Its scope guides freedom-to-operate analyses and patent infringement assessments.
- Broad claims offer a competitive edge but also risk legal scrutiny based on prior art.
Key Takeaways
- The patent claims cover specific chemical compositions, manufacturing processes, and therapeutic applications.
- Its protection scope extends to formulations and uses with precise claim language, which is critical in patent validity.
- The patent landscape shows active competition with multiple filings on similar inventions, requiring detailed freedom-to-operate and validity analyses.
5 FAQs
1. How broad are the claims of IL222432?
Claims include both broad compositions and specific embodiments, with independent claims covering core compounds and uses, and dependent claims detailing variations.
2. What should be considered to assess patent validity?
Prior art references, novelty, inventive step, and claim clarity are critical factors. Patent validity is challenged if prior art discloses similar compositions or methods.
3. Can the patent be enforced in other countries?
Only if equivalent patent applications are filed and granted in those jurisdictions. IL222432's protection is limited to Israel unless family patents exist.
4. How does the patent landscape impact commercialization?
Existing patents can restrict market entry; licensing or patent clearance strategies must consider similar patents owned by competitors.
5. What is the typical patent term for this type of invention?
Patent rights generally last 20 years from the filing date, with potential extensions for regulatory delays, likely expiring around 2039-2040.
References
- Israel Patent Office. (2022). Patent IL222432 documentation.
- WIPO. (2022). Patent Family Reports.
- European Patent Office. (2022). Patent Landscape Reports.
- US Patent and Trademark Office. (2022). Patent Application Database.
- World Intellectual Property Organization. (2022). PatentScope Database.
